When CHIP variants were limited to those genes related to CLL (Supplementary Table 1), we found a 4.88-fold (95% CI: 2.44–9.76, P < 0.001, Table 1) increased risk of lymphoid malignancy. Here, STUB1 is linked to B-cell chronic lymphocytic leukemia.